Reagents

Ended Awarded

Contract number
47QSWA19F4T2Q
Awardee
Awarding agency
Obligated
$72,926

Award facts

Contract value 100% obligated
$72,926.36 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
8520 Toilet Soap, Shaving Preparations, And Dentifrices
Set-aside
No set-aside
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Raritan, NJ 08869, USA

Award details come from SAM.gov/FPDS.

About this award

Ortho-Clinical Diagnostics Inc. was awarded a $72,926.36 firm fixed price blanket purchase agreement (BPA) call contract by the General Services Administration (GSA) Federal Acquisition Service to provide reagents. The contract has no set-aside designation and calls against the GSA's Federal Supply Schedules for Biological Products and Analytical Services and Quality Assurance through Scientific and Technical Assistance available for direct delivery to military and civilian customers. Performance will occur in Raritan, New Jersey.

Quick answers

Who was awarded contract 47QSWA19F4T2Q?

47QSWA19F4T2Q was awarded to Ortho-Clinical Diagnostics, Inc. by Federal Acquisition Service (General Services Administration) on June 13, 2019.

How much is contract 47QSWA19F4T2Q worth?

The government has obligated $72,926 on 47QSWA19F4T2Q.

Is contract 47QSWA19F4T2Q an order under another contract?

Yes. 47QSWA19F4T2Q is a BPA call under 47QSWA19A000L, a blanket purchase agreement.

Was contract 47QSWA19F4T2Q competed?

The extent of competition for 47QSWA19F4T2Q was competed under sap. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award